News search

Researchers at the CNIC, in collaboration with the University of Pavia and IRCCS Istituti Clinici Scientifici Maugeri, have found that activation of the enzyme calpain contributes to the development of a severe inherited arrhythmia.

A new study, published in the Journal of the American Heart Association, shows that individuals with elevated levels of both proteins have twice the risk of cardiovascular events.

The research demonstrates the benefit of a new gene silencer for treating the disease

A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.

The research, presented in a Hot Line session at the European Society of Cardiology Congress in Munich and published simultaneously in The New England Journal of Medicine, proposes a paradigm shift towards prevention based on early detection through vascular imaging

The protein, OMA1, delays immune-system overactivation, liver fibrosis, and liver cancer during aging

The findings suggest that a risk-based personalized approach may be more efficient than applying intensive surveillance protocols uniformly to all patients. 

The Foundation recognises the pioneering research into the link between gut microbiota and cardiovascular disease led by David Sancho at the CNIC